Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125519981 | 12551998 | 1 | I | 201508 | 20160629 | 20160713 | 20160713 | EXP | PHHY2016DE091143 | NOVARTIS | 42.00 | YR | M | Y | 0.00000 | 20160713 | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125519981 | 12551998 | 1 | PS | PANOBINOSTAT | PANOBINOSTAT | 1 | Unknown | U | 205353 | ||||||||||
| 125519981 | 12551998 | 2 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Unknown | U | 0 | ||||||||||
| 125519981 | 12551998 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125519981 | 12551998 | 1 | Acute lymphocytic leukaemia |
| 125519981 | 12551998 | 2 | Acute lymphocytic leukaemia |
| 125519981 | 12551998 | 3 | Acute lymphocytic leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125519981 | 12551998 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125519981 | 12551998 | Acute lymphocytic leukaemia | |
| 125519981 | 12551998 | Facial paresis | |
| 125519981 | 12551998 | Malignant neoplasm progression | |
| 125519981 | 12551998 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |